Published in Lab Business Week, July 23rd, 2006
Colt Ventures, LLC, a Dallas-based venture capital firm, served as lead investor for this financing. Colt Ventures focuses on life sciences, technology, and natural resources.
Darren Blanton, Colt Ventures' managing partner, stated, "We are excited to be affiliated with this project as we recognize its significant potential for treating patients who have suffered heart attacks. This is a strategic beginning in our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.